FLT3 and acute myeloid leukemia: In the remaining four patients (3%), no primary genetic aberration was found, but only mutations that frequently occur as secondary in AML (FLT3-ITD, WT1m, KRASm, NF1m, PTPN11m and KITm; 1–3 mutations per patient) [23].